Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies
Top Cited Papers
Open Access
- 5 December 2013
- journal article
- Published by American Society of Hematology in Blood
- Vol. 122 (24), 3892-3898
- https://doi.org/10.1182/blood-2013-05-498311
Abstract
Recurrent and unpredictable episodes of vaso-occlusion are the hallmark of sickle cell disease. Symptomatic management and prevention of these events using the fetal hemoglobin–reactivating agent hydroxyurea are currently the mainstay of treatment. Discoveries over the past 2 decades have highlighted the important contributions of various cellular and soluble participants in the vaso-occlusive cascade. The role of these elements and the opportunities for therapeutic intervention are summarized in this review.Keywords
This publication has 56 references indexed in Scilit:
- A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodesHaematologica, 2013
- Tissue factor and thrombin in sickle cell anemiaThrombosis Research, 2012
- Intravenous Immunoglobulins Modulate Neutrophil Activation and Vascular Injury Through FcγRIII and SHP-1Circulation Research, 2012
- Hydroxyurea for sickle cell anemia: what have we learned and what questions still remain?Current Opinion in Hematology, 2011
- A pilot study of the short‐term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunctionBritish Journal of Haematology, 2011
- CXCL1 and its receptor, CXCR2, mediate murine sickle cell vaso-occlusion during hemolytic transfusion reactionsJCI Insight, 2011
- Heme oxygenase-1 gene delivery by Sleeping Beauty inhibits vascular stasis in a murine model of sickle cell diseaseJournal of Molecular Medicine, 2010
- Inhaled carbon monoxide reduces leukocytosis in a murine model of sickle cell diseaseAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injuryNature Medicine, 2009
- Sickle Red Cell–Endothelium InteractionsMicrocirculation, 2009